A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
- Citation:
- J Thorac Oncol vol 10 (1) 143-147
- Year:
- 2015
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 4
- Parents:
- 762
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10 CA047577, U10 CA032291, CA33601, U10 CA077658, U10 CA029511, CA47577, CA29165, U10 CA045564, CA41287, U10 CA045808, CA03927, U10 CA031946, U10 CA033601, CA59518, U10 CA180821, CA45808, U10 CA059518, U10 CA035421, CA12046, U10 CA045418, CA35421, CA 37422, CA 21661, U10 CA041287, CA45564, U10 CA047559, U10 CA037422, U10 CA180882, CA21060, U10 CA021661, CA47559, CA45418, U10 CA180833, CA77658, U10 CA180867, CA31946, U10 CA003927
- Corr. Author:
- Rogerio Lilenbaum
- Authors:
- Rogerio Lilenbaum Michael Samuels Xiaofei Wang Feng Ming Kong Pasi A. Jänne Gregory Masters Sreedhar Katragadda Lydia Hodgson Jeffrey Bogart Jeffrey Bradley Everett Vokes
- Networks:
- Study
- CALGB-30605
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Article